Amgen's cyberattack involving stolen patient health information raises critical questions about healthcare cybersecurity, unauthorized access, cloud security, AI governance, and AI-driven threats (AI-DT). This article explores what happened, how similar breaches have affected companies like Novo Nordisk and Change Healthcare, and what healthcare organizations can do to better protect sensitive data.

On July 9, 2026, the U.S. Securities and Exchange Commission (SEC) issued guidance that could change how activist investing works in America. The guidance says that certain investors who fund activist campaigns must be identified in regulatory filings rather than remaining behind the scenes.¹ At first glance, this may sound like a technical regulatory update. It is not. The SEC’s guidance goes to the heart of a simple question: If investors are trying to influence the fut